Terumo matches Abbott's Xience in drug-eluting stent study
Terumo's drug-eluting stent, Nobori, nabbed a bit of Abbott Laboratories' Xience glory as it proved in a large study to be just as effective as the top-selling American brand.
Shape-shifting proteins could aid drug delivery for cancer, infections
Researchers at the U.K.'s University of Cambridge are developing a way to alter DNA in such a way that would allow certain drugs to pass through cell membranes without a hitch.
Study: Artificial pancreas improves overnight care in diabetic children
In a real-life setting, diabetic children fare better with an artificial pancreas than with a sensor-augmented insulin pump when it comes to controlling night-time glucose levels, a new study concludes.
Vaginal nanogel with bee venom could prevent HIV infection
Researchers at the Washington University School of Medicine in St. Louis have taken steps toward the creation of a gel made from bee venom that, when applied vaginally, could help prevent the spread of HIV.
Celgene drops $13M on Presage's 3-D drug delivery platform
Celgene's $13 million investment in Presage Biosciences' cancer drug delivery platform is a major bet on something groundbreaking. The technology is the first of its kind, with the ability to compare treatments across separate sections of a tumor.
PolyPid, MIS Implants partner for drug delivering dental bone-filler
Israeli drug-delivery company PolyPid has partnered with U.S.-based devicemaker MIS Implants Technologies to develop a dual polymer-lipid bone-healing technology specifically for dental use.
Yale researchers improve lupus drug with nanogel delivery
Yale researchers have developed a new nanogel delivery platform to treat autoimmune diseases such as lupus, multiple sclerosis and Type 1 diabetes.
Actium BioSystems puts the heat on cancer with hyperthermic delivery
Actium BioSystems is testing a novel delivery system for treating cancer that employs both heat and chemotherapy in a selectively targeted attack.
Mercator micro-infusion drug delivery catheter snags CE mark
California delivery-device outfit Mercator MedSystems got the OK from European officials to launch two of its micro-infusion catheters, which use tiny needles to deliver drugs directly across artery walls.
Patch-delivered estrogen treats prostate cancer with fewer side effects
Researchers in the U.K. have found that an estrogen patch is an effective way to treat prostate cancer compared with side effects-laden hormone injections and pills.
Combo drug, Dx nanomedicine delivers cancer-fighting payload
Swedish researchers have developed trackable nanoparticles that may be a more targeted and effective delivery tool in the fight against cancer.
West launches intradermal adapter for shallow injections
West Pharmaceutical Services rolled out an adapter for standard needles that enables easier and more consistent delivery into a patient's skin at a very shallow angle.
Sanofi's Genzyme hits target with muscular dystrophy RNA drug in mice
Researchers at Genzyme have found a way to deliver drugs that shut down the genes associated with the neuromuscular disease myotonic dystrophy type 1, a type of muscular dystrophy.
Ocular Therapeutix submits cataract-surgery sealant for FDA approval
Ocular Therapeutix is formally seeking premarket approval with the FDA for its hydrogel-based sealant used to protect the eye after cataract surgery.
Synthetic protein tricks immune system for drug delivery, device safety
Researchers at the University of Pennsylvania have found a way to coat small drug-delivery vehicles and other foreign objects with a synthetic "passport" peptide that fools the immune system into allowing the objects to survive longer in the human body.
SHL ups Taiwanese auto injector production by $40M
Drug-delivery devicemaker SHL is expanding its Taiwan venture by $40 million U.S. this year, investing in facilities for its line of auto injectors, pen injectors and inhalers.
Genentech nabs FDA approval for T-DM1 cancer killer
Roche's Genentech picked up FDA approval for its late-stage breast cancer therapy Kadcyla, formerly T-DM1, which uses antibodies to deliver cancer drugs directly to the offending cells.
Neuralstem licenses spinal stem cell delivery tech for research
Neuralstem's spinal cord delivery platform will get the academic treatment as the company licensed the stem cell therapy for research at Cedars-Sinai Medical Center in Los Angeles.
Stallergenes pursues FDA approval for sublingual allergy tablet
In an effort to bring the first-ever sublingual option for the treatment of severe respiratory allergies to the U.S., French company Stallergenes awaits approval from the FDA for its hay fever treatment Oralair.
Courts: Teva's Cephalon fells Actavis in oral painkiller delivery appeal
A federal appeals court decided in favor of Cephalon in a dispute with Actavis ($ACT) over an oral mucosal drug delivery patent.
